Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Karl Storz Acquires British AI Specialist Innersight Labs

By HospiMedica International staff writers
Posted on 11 Jan 2024

KARL STORZ (Tuttlingen, Germany), a family-owned MedTech company, has acquired Innersight Labs Ltd. (ISL, London, UK), an innovative software manufacturer for an undisclosed amount. Apart from state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ continues its expansion into innovative software solutions. The company’s wide customer base, which includes top-class physicians across the world, can now enjoy access to 3D models created from medical scans, making surgery much easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will significantly enhance the KARL STORZ portfolio.

ISL has developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels the received scans according to different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications. In comparison to competing products, ISL's AI-based algorithm can significantly reduce manual effort, lowering cost per model and time to deployment.

As part of the globally active KARL STORZ Group, ISL will now focus on commercial scaling and joint technology development. The ISL acquisition adds an AI product to the existing KARL STORZ portfolio marking the next step in its efforts to integrate AI into laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ aims to incorporate the extensive possibilities offered by AI into the development of cutting-edge medical technology at an early stage, allowing it to offer the best instruments for patients with the highest safety standards in the market.

Related Links:
KARL STORZ
Innersight Labs Ltd.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Cylindrical Water Scanning System
SunSCAN 3D
New
A4 Medical Color Printer
UP-DR80MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new technology can make heart-related predictions more widely accessible through the use of wearables (Photo courtesy of Fred Zwicky/UIUC)

Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery

The heart's response to physical activity is a vital early indicator of changes in health, particularly in cardiovascular function and mortality. Extensive research has demonstrated a connection between... Read more

Surgical Techniques

view channel
Image: The diffusion model was trained on real LGE-MRI distributions and generated synthetic fibrosis distributions from Gaussian noise (Photo courtesy of Frontiers, DOI: 10.3389/fcvm.2025.1512356)

AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment

Atrial fibrillation (AF) is a common heart rhythm disorder, often linked to the development of fibrosis, which is the formation of scar tissue in the heart. This fibrosis typically arises due to aging,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.